Pandion Therapeutics

Pandion Therapeutics

Pandion Therapeutics is Cambridge based healthcare Startup. Learn more

Launch date
Market cap
-
Enterprise valuation
€1.7b (Public information from Apr 2021)
Cambridge Massachusetts (HQ)
  • Edit
DateInvestorsAmountRound
-

N/A

-

$58.0m

Series A
*

$80.0m

Series B
N/A

$135m

Valuation: $513m

IPO

$1.9b

Valuation: $1.9b

Acquisition
Total Funding€125m

Recent News about Pandion Therapeutics

Edit
More about Pandion Therapeuticsinfo icon
Edit

Pandion Therapeutics is a biotechnology company focused on developing innovative treatments for autoimmune and inflammatory diseases. The company operates in the biopharmaceutical market, serving patients and healthcare providers. Pandion's business model revolves around its proprietary TALON (Therapeutic Autoimmune reguLatOry proteiN) drug design platform, which allows for the creation of modular precision medicine therapeutics. These therapeutics are engineered to achieve lasting therapeutic outcomes by selectively modulating the immune system. The company generates revenue through the development and potential commercialization of its drug candidates, as well as through partnerships and collaborations with other pharmaceutical companies.

Keywords: biotechnology, autoimmune, inflammatory, TALON, precision medicine, immunomodulatory, therapeutics, drug development, healthcare, biopharmaceutical.

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.